Novo invests $6B+ to expand API manufacturing facilities in Denmark for GLP-1, other drugsnews2023-11-10T11:57:58+00:00November 10th, 2023|Endpoints News|
Century Therapeutics nabs Bristol Myers alum as CEO; Enhertu star Daiichi Sankyo makes changes in Europenews2023-11-10T10:41:52+00:00November 10th, 2023|Endpoints News|
Valneva receives first chikungunya vaccine approval after two month delay to FDA reviewnews2023-11-10T09:50:37+00:00November 10th, 2023|Endpoints News|
CAR-T cell therapy biotech CARGO Therapeutics prices $281M IPOnews2023-11-10T01:15:20+00:00November 10th, 2023|Endpoints News|
Illumina expects revenue drop after another guidance cutnews2023-11-09T21:35:59+00:00November 9th, 2023|Endpoints News|
How the price of Lilly’s weight management drug could fuel its rivalry with Novo Nordisknews2023-11-09T20:47:16+00:00November 9th, 2023|Endpoints News|
FDA approves Takeda’s new enzyme replacement therapy for rare blood clotting disordernews2023-11-09T20:09:45+00:00November 9th, 2023|Endpoints News|
ADF asks SCOTUS not to take up mifepristone case as Danco, DOJ say arguments don’t hold upnews2023-11-09T19:48:24+00:00November 9th, 2023|Endpoints News|
Otsuka TV and banner ads for Rexulti draw rebuke from FDA watchdognews2023-11-09T19:41:18+00:00November 9th, 2023|Endpoints News|
How Boehringer Ingelheim and Pfizer battled over the exclusivity of the first Humira interchangeablenews2023-11-09T19:08:43+00:00November 9th, 2023|Endpoints News|
